Perrigo Pharma Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PERRIGO PHARMA INTL, and what generic and branded alternatives to PERRIGO PHARMA INTL drugs are available?
PERRIGO PHARMA INTL has nine approved drugs.
There is one tentative approval on PERRIGO PHARMA INTL drugs.
Drugs and US Patents for Perrigo Pharma Intl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perrigo Pharma Intl | LORATADINE | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 076011-001 | Sep 29, 2003 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Perrigo Pharma Intl | LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 075989-001 | Mar 4, 2004 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Perrigo Pharma Intl | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | SPRAY, METERED;NASAL | 078104-002 | Nov 14, 2014 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Perrigo Pharma Intl | LORATADINE AND PSEUDOEPHEDRINE SULFATE | loratadine; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 076050-001 | Jan 30, 2003 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Perrigo Pharma Intl | PREVACID 24 HR | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 022327-001 | May 18, 2009 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Perrigo Pharma Intl | DICLOFENAC SODIUM | diclofenac sodium | GEL;TOPICAL | 211253-001 | May 16, 2019 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.